Exchange: NASDAQ·Updated 02:41 PM EDT

About

Yarrow Bioscience, Inc. is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The company is developing YB-101, a potentially first-of-its-kind antibody therapy aimed at treating Graves disease (GD) and thyroid eye disease (TED). Yarrow Bioscience was founded in October 2025 and is headquartered in New Haven, CT.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
10

Frequently Asked Questions

What is Market Cap of Yarrow Bioscience Inc.?
What is the 52-week high for Yarrow Bioscience Inc.?
What is the 52-week low for Yarrow Bioscience Inc.?
What is Yarrow Bioscience Inc. stock price today?
What was Yarrow Bioscience Inc. stock price yesterday?
What is the PE ratio of Yarrow Bioscience Inc.?
What is the Price-to-Book ratio of Yarrow Bioscience Inc.?
What is the 50-day moving average of Yarrow Bioscience Inc.?
How many employees does Yarrow Bioscience Inc. have?

Advertisement|Remove ads.